Published in Microb Pathog on February 01, 1999
Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 5.92
Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev (2001) 3.58
Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis (2005) 2.43
Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun (2000) 2.00
Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2009) 1.95
Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect Immun (2006) 1.67
The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun (2009) 1.36
NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis. J Bacteriol (2005) 1.35
Detection of large numbers of pneumococcal virulence genes in streptococci of the mitis group. J Clin Microbiol (2010) 1.32
Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection. Proc Natl Acad Sci U S A (2003) 1.19
Genetic requirement for pneumococcal ear infection. PLoS One (2007) 1.16
Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model. Infect Immun (2004) 1.06
Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization. Infect Immun (2005) 1.01
Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa. Biochem J (2005) 1.00
BgaA acts as an adhesin to mediate attachment of some pneumococcal strains to human epithelial cells. Microbiology (2011) 0.94
Characterization of the Streptococcus pneumoniae BgaC protein as a novel surface beta-galactosidase with specific hydrolysis activity for the Galbeta1-3GlcNAc moiety of oligosaccharides. J Bacteriol (2009) 0.93
Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2. Infect Immun (2010) 0.91
Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clin Exp Immunol (2004) 0.90
Cloning, expression, and characterization of a neuraminidase gene from Arcanobacterium pyogenes. Infect Immun (2001) 0.90
Structural insights into the substrate specificity of Streptococcus pneumoniae β(1,3)-galactosidase BgaC. J Biol Chem (2012) 0.89
Modulation of adherence, invasion, and tumor necrosis factor alpha secretion during the early stages of infection by Streptococcus pneumoniae ClpL. Infect Immun (2007) 0.88
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media. Clin Vaccine Immunol (2006) 0.87
Identification of a second Arcanobacterium pyogenes neuraminidase and involvement of neuraminidase activity in host cell adhesion. Infect Immun (2002) 0.83
The complex link between influenza and severe sepsis. Virulence (2013) 0.81
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Mol Immunol (2015) 0.79
Milk proteins, peptides, and oligosaccharides: effects against the 21st century disorders. Biomed Res Int (2015) 0.75
The Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host Glycoconjugates. EBioMedicine (2017) 0.75
Effects of Infant Formula with Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. J Pediatr Gastroenterol Nutr (2017) 0.75
A Study in Extensive Cutaneous Burns. Ann Surg (1933) 12.72
A STUDY OF THE EFFECTS OF PYLORIC OBSTRUCTION IN RABBITS. J Clin Invest (1925) 10.25
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 7.10
Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob Agents Chemother (1989) 5.80
DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol (1990) 5.13
4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob Agents Chemother (1991) 4.35
Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J Bacteriol (1996) 4.34
DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein. Proc Natl Acad Sci U S A (1979) 4.34
Nucleotide sequence of the Staphylococcus aureus gyrB-gyrA locus encoding the DNA gyrase A and B proteins. J Bacteriol (1992) 3.95
DNA gyrase action involves the introduction of transient double-strand breaks into DNA. Proc Natl Acad Sci U S A (1980) 3.87
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother (1997) 3.83
THE ROLE OF THE BACILLUS WELCHII IN ACUTE INTESTINAL OBSTRUCTION: WITH LIGATION OF THE VEINS TO THE OBSTRUCTED LOOP. Ann Surg (1929) 3.18
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 3.12
DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance. J Bacteriol (1990) 2.96
Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1991) 2.80
Site-specific interaction of DNA gyrase with DNA. Proc Natl Acad Sci U S A (1981) 2.75
Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun (2000) 2.00
Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect Immun (1988) 1.96
Interaction of bleomycin A2 with deoxyribonucleic acid: DNA unwinding and inhibition of bleomycin-induced DNA breakage by cationic thiazole amides related to bleomycin A2. Biochemistry (1985) 1.94
DNase I hypersensitive sites in the chromatin of human mu immunoglobulin heavy-chain genes. Nature (1984) 1.94
Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob Agents Chemother (1999) 1.73
Experimental otitis media with effusion following middle ear inoculation of nonviable H influenzae. Ann Otol Rhinol Laryngol (1984) 1.55
gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. J Infect Dis (1991) 1.54
DNA gyrase complex with DNA: determinants for site-specific DNA breakage. EMBO J (1986) 1.52
Potent antipneumococcal activity of gemifloxacin is associated with dual targeting of gyrase and topoisomerase IV, an in vivo target preference for gyrase, and enhanced stabilization of cleavable complexes in vitro. Antimicrob Agents Chemother (2000) 1.45
DNA supercoiling and gene expression. Nature (1984) 1.35
Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun (2000) 1.33
Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect Immun (2001) 1.30
Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob Agents Chemother (2001) 1.27
Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. Microb Pathog (2001) 1.26
Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion. J Clin Microbiol (1984) 1.26
TERATOID MIXED TUMORS OF THE BREAST: REPORT OF A CASE. Ann Surg (1923) 1.25
Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob Agents Chemother (2000) 1.25
Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells. FEBS Lett (1990) 1.24
Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases. Biochim Biophys Acta (1993) 1.24
Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast. Cancer Res (1993) 1.23
Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J (1992) 1.19
Aging and speed of behavior: possible consequences for psychological functioning. Annu Rev Psychol (1995) 1.17
DNA gyrase: site-specific interactions and transient double-strand breakage of DNA. Cold Spring Harb Symp Quant Biol (1981) 1.16
Quantitative evaluation of dizziness characteristics and impact on quality of life. Am J Otol (1996) 1.14
Pulmonary infection of mice with Staphylococcus aureus. Infect Immun (1978) 1.14
Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Microb Pathog (1992) 1.13
Cytological and histological changes in the middle ear after inoculation of influenza A virus. Acta Otolaryngol (1993) 1.13
Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann Otol Rhinol Laryngol (2000) 1.12
Effect of intranasal inoculation of Streptococcus pneumoniae on the structure of the surface carbohydrates of the chinchilla eustachian tube and middle ear mucosa. Microb Pathog (1994) 1.10
Expression, domain structure, and enzymatic properties of an active recombinant human DNA topoisomerase II beta. J Biol Chem (1995) 1.09
BODY FLUID CHANGES DUE TO CONTINUED LOSS OF THE EXTERNAL SECRETION OF THE PANCREAS. J Exp Med (1928) 1.08
Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms. Antimicrob Agents Chemother (1999) 1.06
ACID-BASE COMPOSITION OF PANCREATIC JUICE AND BILE. J Exp Med (1928) 1.06
Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model. Infect Immun (2004) 1.06
Effects of inhaled endotoxin-containing bacteria. Environ Res (1980) 1.05
Peptidoglycan isolated from nontypeable Haemophilus influenzae induces experimental otitis media in the chinchilla. J Infect Dis (1994) 1.04
Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion. Ann Otol Rhinol Laryngol (1998) 1.04
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants. Infect Immun (2001) 1.03
Differential expression of cytokine genes and inducible nitric oxide synthase induced by opacity phenotype variants of Streptococcus pneumoniae during acute otitis media in the rat. Infect Immun (2003) 1.02
Immunological responsiveness of chinchillas to outer membrane and isolated fimbrial proteins of nontypeable Haemophilus influenzae. Infect Immun (1989) 1.02
Experimental otitis media with effusion induced by nonviable Hemophilus influenzae: cytologic and histologic study. Am J Otolaryngol (1984) 1.02
Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization. Infect Immun (2005) 1.01
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180). Mol Pharmacol (1996) 0.99
Panel discussion: pathogenesis of otitis media. Bacteriology and immunology. Laryngoscope (1982) 0.95
Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast. Cancer Chemother Pharmacol (1997) 0.95
Energetics of proline racemase: tracer perturbation experiments using [14C]proline that measure the interconversion rate of the two forms of free enzyme. Biochemistry (1986) 0.95
Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha. Mol Pharmacol (2000) 0.94
Analysis of a chimeric class-I patatin-GUS gene in transgenic potato plants: High-level expression in tubers and sucrose-inducible expression in cultured leaf and stem explants. Plant Mol Biol (1989) 0.93
Biotypes of serologically nontypable Haemophilus influenzae isolated from the middle ears and nasopharynges of patients with otitis media with effusion. J Clin Microbiol (1984) 0.93
Nucleotide sequence of the recF gene cluster from Staphylococcus aureus and complementation analysis in Bacillus subtilis recF mutants. Mol Gen Genet (1995) 0.92
Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity. Mol Pharmacol (1997) 0.92
Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants. Infect Immun (2003) 0.91
Endotoxin permeability through the round window. Acta Otolaryngol Suppl (1989) 0.91
Cross-reactive antibodies in type b and nontypeable Hemophilus influenzae-induced experimental otitis media. Ann Otol Rhinol Laryngol (1987) 0.91
Regulation of DNA supercoiling in Escherichia coli: genetic basis of a compensatory mutation in DNA gyrase. FEBS Lett (1989) 0.91
An Escherichia coli DNA topoisomerase I mutant has a compensatory mutation that alters two residues between functional domains of the DNA gyrase A protein. J Bacteriol (1992) 0.90
Current concepts of pathogenesis of otitis media: a review. Acta Otolaryngol Suppl (1988) 0.89
Whole blood viscosity in preeclampsia. Am J Obstet Gynecol (1982) 0.89
Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions. Surgery (1972) 0.89
Energetics of proline racemase: racemization of unlabeled proline in the unsaturated, saturated, and oversaturated regimes. Biochemistry (1986) 0.88
The pathogenesis of hypertensive vascular changes in the rat: microscopic and ultrastructural correlation in vivo. Clin Sci Mol Med Suppl (1976) 0.86
Deinduction of phosphoenolpyruvate carboxykinase (guanosine triphosphate) synthesis in Reuber H-35 cells. J Biol Chem (1975) 0.86
Primary culture of chinchilla middle ear epithelium. Ann Otol Rhinol Laryngol (1991) 0.86
DNA supercoiling by DNA gyrase. Nature (1981) 0.86
The effect of antecedent influenza A virus infection on the adherence of Hemophilus influenzae to chinchilla tracheal epithelium. Am J Otolaryngol (1988) 0.85
Amsacrine-promoted DNA cleavage site determinants for the two human DNA topoisomerase II isoforms alpha and beta. Biochem Pharmacol (1996) 0.84
Novel selection and genetic characterisation of an etoposide-resistant human leukaemic CCRF-CEM cell line. Br J Cancer (1993) 0.83
Recent advances in otitis media. Microbiology, immunology, biochemistry, and vaccination. Ann Otol Rhinol Laryngol Suppl (1989) 0.83
Recovery of Chlamydia trachomatis from patients of southeastern venereal disease clinic. Am J Clin Pathol (1980) 0.83
Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail. Exp Cell Res (1998) 0.83
Identification of a factor IX point mutation using SSCP analysis and direct sequencing. Nucleic Acids Res (1990) 0.83
THE ACID-BASE COMPOSITION OF GASTRIC SECRETIONS. J Exp Med (1928) 0.83
Molecular cloning and expression of the Candida albicans TOP2 gene allows study of fungal DNA topoisomerase II inhibitors in yeast. Biochem J (1997) 0.82
Aging and slowing of behavior: consequences for cognition and survival. Nebr Symp Motiv (1991) 0.82
DNA topoisomerases: enzymes that change the shape of DNA. Sci Prog (1990) 0.82
Experience in the treatment of hepatic failure by intermittent liver hemoperfusions. Surg Gynecol Obstet (1973) 0.82
Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. Bioorg Med Chem Lett (2006) 0.81
Phagocytosis and killing of bacteria by middle ear macrophages. Arch Otolaryngol Head Neck Surg (1987) 0.81
NorA plasmid resistance to fluoroquinolones: role of copy number and norA frameshift mutations. Antimicrob Agents Chemother (1996) 0.81
Structure and partial amino acid sequence of calf thymus DNA topoisomerase II: comparison with other type II enzymes. Biochem Biophys Res Commun (1990) 0.81
Effect of tumor necrosis factor alpha and interleukin 1-alpha on the adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol (1999) 0.81
DNA binding and intercalation by novel porphyrins: role of charge and substituents probed by DNase I footprinting and topoisomerase I unwinding. FEBS Lett (1990) 0.81